Dr. Malgorzata Szerszeniewska
Chief Executive Officer
Szerszeniewska is a co-founder of EastHORN. Previously, she was president of AbCRO, Inc., an American-owned CRO operating in Europe. Prior to that Dr. Szerszeniewska spent more than 10 years at Covance, where she held various positions including Regional Resource Manager, Project Manager, Director of Strategic Development and Clinical Operations in Europe, and was responsible for development of the company’s Clinical Development Services in the European region.
Before joining the CRO industry, she worked as an Anesthesiology and Intensive Care Specialist at Warsaw University Hospital. Dr. Szerszeniewska’s therapeutic experience includes oncology, neurology, cardiovascular, psychiatry and gastrointestinal medicine. Dr. Szerszeniewska received her Medical Diploma from the Warsaw Medical University.
Dr. Alan Wood
Dr. Wood co-founded EastHORN. He has 30 years experience in pharmaceutical research and development, both in pharmaceutical companies and in CROs. Most recently, he was Senior Director, R&D Operations at Nicox SA, a French biotechnology company. Previously, Dr. Wood was General Manager, Europe and Asia-Pacific at Covance and prior to that at Quintiles in a range of general management roles. He started his clinical development career with Sandoz (now Novartis) in Switzerland.
Dr Wood graduated in pharmacy and pharmacology from the University of Otago, New Zealand.
Demand from our clients has encouraged us to expand to other countries in Western Europe with similar advantages: access to patients and high-quality investigator sites.
As we grow and expand our geographic reach we are determined to keep the characteristics of a small company: responsive, nimble, easy to work with, senior management involvement in operations and a commitment to the highest professional standards.”
Chief Business Officer
Iain joined EastHORN in 2013 to play a key role in the next stages of EastHORN’s ambitious plans for growth. He has been managing CRO business development in Europe and North America for more than 15 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services in this region and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry.
Iain is based in the UK and graduated in Cell Biology from the University of Glasgow.
Head of Project Management
Ms Mohlberg joined EastHORN at the beginning of 2013 and established the office in Cologne, Germany to further enhance our services for Western European and German clients. She has worked in the clinical research field for over 16 years and is very aware of the important role of European countries in almost all clinical trials and the constant growth in the region
Having previously worked for both CROs and pharma companies, she is very familiar with the clinical research environment in Germany and internationally. With her understanding of the structure and needs, as well as challenges of the pharmaceutical industry, she ensures that the services delivered to our clients by our project teams are of the highest quality.
Ms Mohlberg graduated in biology from the University of Giessen, Germany
Dr. Tandy Amure
Chief Medical Officer
Dr Tandy Amure has over 24 years experience working as a physician within the CRO industry. She held posts as Clinical Research Physician and Principal Investigator at Phase I/Clinical Pharmacology units, before joining Covance in 1997, as Pharmaceutical Development Physician.
She had increasing roles and responsibilities during her 18 year tenure with Covance, working up to the position of Senior Medical Director, a position she held for 10 years. Dr Amure has extensive experience in medical monitoring, business development, process improvements, mentoring and client facing situations. She brings a wealth of experience in clinical development across multiple therapeutic areas and phases of clinical development.
Dr Amure is a Rheumatologist by training, and obtained her medical degree from the University of Bristol, UK in 1988. She also has a BSc (Hons) in Physiology and a Masters degree in Pharmacology.
Dr Amure is based in the UK, and is GMC Registered.